Development of an organotypic high-throughput screening assay kit to determine predictability of anti-cancer drugs in 3D QGel

Forschungsstelle

INNOSUISSE

Projektnummer

14011.2 PFLS-LS

Projekttitel

Development of an organotypic high-throughput screening assay kit to determine|predictability of anti-cancer drugs in 3D QGel

Projekttitel Englisch

Development of an organotypic high-throughput screening assay kit to determine|predictability of anti-cancer drugs in 3D QGel

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Kurzbeschreibung		-	-
Abstract		-	-

Kategorie	Text
Kurzbeschreibung (Deutsch)	Development of an organotypic high-throughput screening assay kit to determine predictability of anti-cancer drugs in 3D QGel
Kurzbeschreibung (Englisch)	Development of an organotypic high-throughput screening assay kit to determine\|predictability of anti-cancer drugs in 3D QGel
Abstract (Deutsch)	This project brings together the start-up company QGel and academic cancer and matrix\|biology experts in order to develop proven QGel technology into a 3D cell-based highthroughput\|assay kit for primary patient-derived cancer cells. Commercially available anticancer\|drugs will be tested on these tumor models grown in vitro with QGel technology.\|Based on indications by cancer experts, QGel drug-tumor response data are collected and\|compared to clinical data of these drugs.
Abstract (Englisch)	This project brings together the start-up company QGel and academic cancer and matrix\|biology experts in order to develop proven QGel technology into a 3D cell-based highthroughput\|assay kit for primary patient-derived cancer cells. Commercially available anticancer\|drugs will be tested on these tumor models grown in vitro with QGel technology.\|Based on indications by cancer experts, QGel drug-tumor response data are collected and\|compared to clinical data of these drugs.